Insider · CIK 0001321937
Linda M Rubinstein
cfoofficer
Files at ADVM (Adverum Biotechnologies, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | MOption exercise Common Stock | +48,750 | $4.20 | $205k | 61,150 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | UTender of shares Common Stock | -61,150 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | UTender of shares Common Stock - Restricted Stock Units | -8,125 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Common Stock - Performance Stock Units | +42,000 | $0.00 | $0 | 42,000 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | UTender of shares Common Stock - Performance Stock Units | -42,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -85,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -62,083 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -48,750 | - | - | 0 | Dec 10, 2025 |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -85,000 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +85,000 | $0.00 | $0 | 85,000 | Jun 20, 2025 |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 20, 2025 |
| Feb 25, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Common Stock | +8,125 | $0.00 | $0 | 19,325 | Feb 27, 2025 |
| Feb 25, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +48,750 | $0.00 | $0 | 48,750 | Feb 27, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.